Current epidemiological evidence does not support a causal link between Roundup exposure and multiple myeloma. The most comprehensive studies and meta-analyses available show relative risks hovering close to 1.0, meaning exposed populations develop the disease at roughly the same rate as unexposed ones. That said, the evidence base is thin, and the question is more complicated than a clean yes or no, partly because Roundup is not the same thing as glyphosate, and partly because separating the effects of one pesticide from the dozens farmers typically use has proven enormously difficult.
What the Largest Studies Have Found
The biggest body of data on this question comes from the Agricultural Health Study (AHS), a long-running U.S. cohort that has tracked tens of thousands of licensed pesticide applicators and their spouses since the mid-1990s. A re-analysis of the full AHS dataset found a relative risk of about 1.1 for “ever use” of glyphosate and multiple myeloma, with wide confidence intervals that crossed 1.0 in both directions, meaning the result was not statistically significant. Adjusting for lifestyle factors and use of ten other pesticides barely changed the number. There was also no dose-response trend: people who reported more cumulative days of glyphosate use did not have higher myeloma risk than those with fewer days of use.1International Journal of Environmental Research and Public Health. Multiple myeloma and glyphosate use: a re-analysis of US Agricultural Health Study (AHS) data
A separate meta-analysis pooling the available studies on glyphosate and multiple myeloma, published in 2020, arrived at a combined relative risk of 1.04, again with confidence intervals comfortably spanning 1.0. Essentially no elevated risk was detectable.2PubMed Central. Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis A systematic review by an expert panel reached a similar conclusion, noting that the case-control data on myeloma specifically were “too sparse to enable an informed causal judgment.”3Critical Reviews in Toxicology. Glyphosate epidemiology expert panel review: a weight of evidence systematic review of the relationship between glyphosate exposure and non-Hodgkin’s lymphoma or multiple myeloma
This is an important distinction from the more widely publicized question about non-Hodgkin lymphoma (NHL), which has generated much larger studies, more conflicting data, and the high-profile legal battles you’ve probably heard about. The myeloma research simply hasn’t reached that volume. With only a handful of studies and no consistent signal, the honest scientific summary is that there is no convincing evidence of a link, but also no large body of evidence that can definitively rule one out.
Where the “Doubled Risk” Claim Came From
If you’ve seen headlines or legal arguments suggesting Roundup doubles the risk of multiple myeloma, those trace back to an earlier AHS analysis that used a restricted subset of the data rather than the full cohort. When the full dataset was analyzed, that doubling vanished. The re-analysis specifically identified the restricted dataset as unrepresentative, and the inflated risk estimate disappeared once the full population was included.1International Journal of Environmental Research and Public Health. Multiple myeloma and glyphosate use: a re-analysis of US Agricultural Health Study (AHS) data
This is worth understanding because older numbers from preliminary or subset analyses persist in public discussion and legal filings long after they’ve been superseded. In epidemiology, early analyses of a cohort often use whatever data is available at the time, and results can shift substantially when the full follow-up becomes available. That’s exactly what happened here.
Roundup Is Not Just Glyphosate
One of the most underappreciated complications in this area is that Roundup, the commercial product, contains more than just glyphosate. The active herbicidal ingredient is glyphosate, but the formulation also includes surfactants that help the chemical spread and stick to plant surfaces. The first generation of these surfactants, called polyethoxylated tallow amines (POEA), are markedly more toxic than glyphosate itself.4Food and Chemical Toxicology. Insight into the confusion over surfactant co-formulants in glyphosate-based herbicides Studies in fruit flies have confirmed that the commercial Roundup product and the POEA surfactant alone are both more toxic than pure glyphosate, reducing lifespan and impairing cell viability through enhanced cell death.5Ecotoxicology and Environmental Safety. The surfactant polyethoxylated tallowamine (POEA) reduces lifespan and inhibits fecundity in Drosophila melanogaster- In vivo and in vitro study
This matters because most toxicological studies test glyphosate in isolation, while most real-world exposure involves the full commercial formulation. It also means that studies finding harm from “Roundup” may be picking up effects from the surfactant rather than from glyphosate. And studies finding glyphosate safe in isolation may be missing hazards that exist in actual products. The regulatory world has started to pay attention to this disconnect, but it muddies the evidence base considerably. When someone asks whether Roundup causes a particular cancer, they’re effectively asking about a cocktail, not a single chemical.
What Happens at the Cellular Level
Even if the epidemiological signal for myeloma is weak, researchers have looked at whether glyphosate or Roundup can cause the kinds of cellular damage that might eventually lead to cancer. The findings are mixed and dose-dependent.
At concentrations considered environmentally relevant, glyphosate did not cause significant genotoxicity or cytotoxicity in cultured human white blood cells. It didn’t increase chromosomal aberrations or markers of DNA oxidative damage. Only at the highest tested concentration, far above what people typically encounter, did researchers observe a slight increase in a marker called sister chromatid exchange.6PubMed. Genotoxicity of Glyphosate on Cultured Human Lymphocytes A different lab study, however, found that chromosomal aberrations and micronuclei (a sign of chromosomal breakage) increased at most tested concentrations of glyphosate in human lymphocytes.7PubMed. In vitro evaluation of genomic damage induced by glyphosate on human lymphocytes
These kinds of contradictions are common in cell-culture toxicology, where small differences in exposure duration, concentration, cell type, and purity of the chemical tested can produce opposite results. What does come through more consistently across studies is that both glyphosate and commercial Roundup formulations increase reactive oxygen species (ROS), a form of cellular stress. In liver cells, ROS levels rose substantially with exposure to both pure glyphosate and the commercial product, and the effect was tied to activation of a signaling pathway involved in cell growth and survival.8PubMed. Alterations in cell viability, reactive oxygen species production, and modulation of gene expression involved in mitogen-activated protein kinase/extracellular regulating kinase signaling pathway by glyphosate and its commercial formulation in hepatocellular carcinoma cells Roundup has also been shown to disrupt mitochondrial function and trigger oxidative stress in other cell types.9PubMed Central. Roundup® induces premature senescence of mouse granulosa cells via mitochondrial ROS-triggered NLRP3 inflammasome activation10PubMed Central. The effects of low-toxic herbicide Roundup and glyphosate on mitochondria
Oxidative stress and mitochondrial disruption are plausible contributors to cancer development in general. But plausible mechanism does not equal demonstrated cause. Plenty of chemicals produce oxidative stress in lab settings without being linked to specific cancers in humans. For multiple myeloma specifically, there is no established mechanistic chain from glyphosate exposure to the aberrant plasma cell proliferation that defines the disease.
The Confounding Problem in Farming Populations
Nearly all the human data we have on glyphosate and multiple myeloma comes from agricultural workers. This introduces a fundamental problem: farmers don’t use just one pesticide. Real-world occupational exposure involves mixtures, often dozens of different chemicals applied across growing seasons. Separating the effect of any single product is extremely difficult, and researchers studying myeloma have specifically noted that accounting for multiple pesticide exposures is essential because it better reflects how exposure actually occurs.11PubMed. Multiple pesticide exposures and the risk of multiple myeloma in Canadian men
Making this even trickier is the so-called healthy worker effect. Farmers as a group tend to have lower overall cancer rates than the general population, likely because of lower smoking rates and higher physical activity. A large international consortium of agricultural cohort studies found that cancer incidence among agricultural workers was about 25 to 30 percent lower than in the general population.12PubMed Central. Cancer incidence in agricultural workers: Findings from an international consortium of agricultural cohort studies (AGRICOH)13Environmental Epidemiology. Cancer incidence in agricultural cohorts: an international consortium of agricultural cohort studies (AGRICOH) That lower baseline rate can mask a real but modest increase in risk from a specific exposure. If farming in general protects against cancer through lifestyle factors, a pesticide that slightly raises risk might still leave exposed farmers with a total cancer rate that looks no different from, or even better than, the general public.
How Much Glyphosate Gets Into Your Body
Understanding exposure levels helps put the risk question into context. Glyphosate is now detectable in the urine of most people, not just farmers. In a U.S. study comparing male farmers with recent glyphosate use, farmers with high lifetime use, farming controls, and nonfarming controls, the chemical was found in about 81 percent of nonfarmers’ urine samples. Among farmers who had applied glyphosate the day before, concentrations were roughly five times higher than in nonfarmers.14PubMed Central. Urinary biomonitoring of glyphosate exposure among male farmers and nonfarmers in the Biomarkers of Exposure and Effect in Agriculture (BEEA) study
Protective equipment makes a measurable difference. Farmers who didn’t wear gloves while applying glyphosate had roughly double the urinary concentrations of those who did. Skipping long-sleeved shirts during mixing also doubled levels.14PubMed Central. Urinary biomonitoring of glyphosate exposure among male farmers and nonfarmers in the Biomarkers of Exposure and Effect in Agriculture (BEEA) study Among Italian vineyard workers, glyphosate was undetectable in urine before application and appeared in every worker afterward, with some showing concentrations nearly fifty times the detection limit.15PubMed Central. Short occupational exposure to glyphosate and its biomonitoring via urinary levels of glyphosate and metabolite AMPA (Amino-MethylPhosphonic acid), in Italian vineyard workers The good news from a toxicokinetic perspective is that the body clears glyphosate fairly quickly: urinary levels peak around 11 hours after exposure and the half-life in the body ranges from about 7 to 18 hours, depending on the pattern of exposure.16PubMed. Urinary glyphosate kinetics after occupational exposure
The widespread detection in nonfarmers raises its own questions. Dietary exposure from residues on food is the presumed route for most people, but at much lower levels than occupational contact. Whether these background-level exposures carry any meaningful health risk remains unclear and is an active area of research.
The Regulatory Disagreement
Part of the public confusion around Roundup and cancer stems from the fact that major regulatory and scientific bodies have reached different conclusions about glyphosate’s carcinogenicity. In 2015, the International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans,” based primarily on evidence related to non-Hodgkin lymphoma and some animal studies. The European Food Safety Authority (EFSA), the U.S. Environmental Protection Agency (EPA), and other regulators concluded the opposite, that glyphosate is unlikely to be carcinogenic in humans at realistic exposure levels.
These bodies were partly looking at different datasets, but they also used different methodological approaches to weigh the same evidence. IARC evaluates hazard (can something cause cancer under any circumstances?), while regulatory agencies evaluate risk (does it cause cancer at the levels people actually encounter?). A review comparing the EU and IARC assessments concluded that both the data differences and the methodological differences contributed to the divergence.17PubMed Central. Glyphosate toxicity and carcinogenicity: a review of the scientific basis of the European Union assessment and its differences with IARC Neither assessment focused specifically on multiple myeloma, so the regulatory disagreement doesn’t directly resolve the myeloma question, but it does explain why people encounter such contradictory-sounding claims about Roundup safety.
Immune Effects and the Gut Microbiome
Multiple myeloma is a cancer of the immune system, specifically of plasma cells, so researchers have explored whether pesticides including glyphosate can disrupt immune function. Pesticides as a broad class have been shown to interfere with both innate and adaptive immune responses, affecting cell-mediated and antibody-mediated immunity.18PubMed. Toxic effects of pesticides on cellular and humoral immunity: an overview This is relevant to myeloma’s origins, but the evidence is not specific enough to glyphosate to draw direct conclusions.
A more recent and intriguing line of research involves the gut microbiome. In mice given low doses of glyphosate at levels considered “acceptable daily intake,” the composition of gut bacteria shifted substantially. The bacterial metabolic pathways involved in producing short-chain fatty acids, which have anti-inflammatory effects, were reduced. At the same time, pro-inflammatory immune cells in the gut lining increased, while anti-inflammatory regulatory cells did not, tipping the balance toward inflammation. Markers of gut inflammation also rose.19PubMed Central. Low-dose glyphosate exposure alters gut microbiota composition and modulates gut homeostasis Chronic low-grade inflammation is a recognized risk factor for many cancers, including blood cancers. But this is a mouse study, and the leap from altered gut bacteria to human myeloma is an enormous one. It opens a research door without walking through it.
Other Established Risk Factors for Multiple Myeloma
Multiple myeloma remains a relatively rare cancer, and its causes are poorly understood compared to many solid tumors. Known or suspected risk factors include age (most diagnoses occur after 65), male sex, Black ancestry (roughly double the incidence compared to white populations), obesity, and a personal history of the precursor condition called MGUS (monoclonal gammopathy of undetermined significance). Family history plays a modest role as well.
Occupational exposures that have been more consistently linked to myeloma than glyphosate include certain solvents and industrial chemicals. A Danish study of occupational risk factors found that probable exposure to vinyl chloride was associated with increased myeloma risk, rising to about fivefold with longer exposure.20PubMed. Occupational risk factors for multiple myeloma among Danish men Benzene and petroleum-related exposures have also been studied, though the evidence varies in strength. The broader point is that if you’re concerned about occupational exposures and myeloma, the strongest associations in the literature involve chemicals other than glyphosate.
Glyphosate and Lymphoma Compared to Myeloma
It’s worth separating the myeloma question from the lymphoma question, because they’re often conflated in public discussion. Both are cancers of white blood cells, but they involve different cell types and different biological mechanisms. The glyphosate-NHL debate has generated far more data, including the IARC classification and the landmark Roundup litigation. The glyphosate-myeloma question, by contrast, has attracted far less research attention.
Even the lymphoma evidence is not clearcut. An Italian multicenter study of occupational glyphosate exposure found no association with lymphoma as a group, including non-Hodgkin lymphoma and B-cell lymphoma, except for one specific subtype, follicular lymphoma.21PubMed Central. Occupational exposure to glyphosate and risk of lymphoma: results of an Italian multicenter case-control study The pattern here is consistent with what’s been seen for myeloma: when researchers look closely at the data rather than at headlines, the associations are small, inconsistent, or absent. The legal system has reached different conclusions from the scientific literature in some cases, which is not unusual since the standard of evidence in court (more likely than not) is lower than the standard for establishing causation in science.
For anyone personally worried about Roundup and blood cancers, the practical takeaway is straightforward. If you use glyphosate-based herbicides at home or at work, wearing gloves and long sleeves during mixing and application measurably reduces how much enters your body. If you work in agriculture and are exposed to many pesticides, the question worth asking isn’t just about glyphosate in isolation, but about cumulative chemical exposure across all the products you handle. And if you’re looking for established, modifiable risk factors for multiple myeloma specifically, maintaining a healthy weight and avoiding known carcinogens like benzene and vinyl chloride are better-supported strategies than worrying about Roundup alone.